EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates

Sophie Reissier, Malo Penven, François Guérin iD, Vincent Cattoir iD

Microorganisms · 01.06.2023 · 11 (6) · 1474

DOI: 10.3390/microorganisms11061474 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 01.06.2023. Verfasst von Sophie Reissier und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rennes University Hospital, Department of Clinical Microbiology, F-35033 Rennes, France. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaerobic bacteria are normal inhabitants of the human commensal microbiota and play an important role in various human infections. Tedious and time-consuming, antibiotic susceptibility testing is not routinely performed in all clinical microbiology laboratories, despite the increase in antibiotic resistance among clinically relevant anaerobes since the 1990s. β-lactam and metronidazole are the key molecules in the management of anaerobic infections, to the detriment of clindamycin. β-lactam resistance is usually mediated by the production of β-lactamases. Metronidazole resistance remains uncommon, complex, and not fully elucidated, while metronidazole inactivation appears to be a key mechanism. The use of clindamycin, a broad-spectrum anti-anaerobic agent, is becoming problematic due to the increase in resistance rate in all anaerobic bacteria, mainly mediated by Erm-type rRNA methylases. Second-line anti-anaerobes are fluoroquinolones, tetracyclines, chloramphenicol, and linezolid. This review aims to describe the up-to-date evolution of antibiotic resistance, give an overview, and understand the main mechanisms of resistance in a wide range of anaerobes.

Schlagwörter

Stichwörter der Autor:innen

anaerobesantimicrobial resistanceclindamycinevolutionmetronidazoleβ-lactams

Autor:innen und Institutionen

  • Rennes University Hospital, Department of Clinical Microbiology, F-35033 Rennes, France.
  • UMR_S1230 BRM, Inserm, University of Rennes, F-35043 Rennes, France.
  • CHU de Rennes, Service de Bactériologie-Hygiène Hospitalière, 2 Rue Henri Le Guilloux, CEDEX 9, F-35033 Rennes, France.

ORCID-Profile: François Guérin, Vincent Cattoir

Zitieren

APA

Reissier, S., Penven, M., Guérin, F., & Cattoir, V. (2023). Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates. Microorganisms, 11(6), 1474. https://doi.org/10.3390/microorganisms11061474

Vancouver

Reissier S, Penven M, Guérin F, Cattoir V. Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates. Microorganisms. 2023;11(6):1474. doi:10.3390/microorganisms11061474

BibTeX
@article{Reissier2023,
  author = {Reissier, Sophie and Penven, Malo and Guérin, François and Cattoir, Vincent},
  title = {Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {6},
  pages = {1474},
  doi = {10.3390/microorganisms11061474}
}
Kostenlos starten →